The FSA fingers Pan Pharmaceutical products in the UK
20 June 2003
The second largest formulator of dietary supplements in the world feels the pain globally, after its license was suspended in Australia in late April. It is widely felt in industry circles that this suspension was overly harsh, particularly considering that the quality control problems that initiated the ban were primarily confined to a pharmaceutical product, rather than natural healthcare pro